Bibliografías temáticas / Sodium polystyrene sulphonate

Literatura académica sobre el tema "Sodium polystyrene sulphonate"

Autor: Grafiati
Publicado: 18 de mayo de 2024

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Índice

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Sodium polystyrene sulphonate".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Sodium polystyrene sulphonate"

1

Harrison, Ian y Jennifer J. W. Higgo. "The preparation of 125I-labelled sodium polystyrene sulphonate". Applied Radiation and Isotopes 45, n.º 3 (marzo de 1994): 345–51. http://dx.doi.org/10.1016/0969-8043(94)90049-3.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Dalvi, Anant G., Sridevi Allu, Massoma Niazi y Gilda Diaz-Fuentes. "SODIUM POLYSTYRENE SULPHONATE (KAYEXALATE) ASPIRATION: AN INCIDENTAL NECROPSY FINDING". Chest 130, n.º 4 (octubre de 2006): 309S. http://dx.doi.org/10.1378/chest.130.4_meetingabstracts.309s-a.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Ghazouani, Anis, Sondes Boughammoura y Jalel M'Halla. "Studies of Electrolytic Conductivity of Some Polyelectrolyte Solutions: Importance of the Dielectric Friction Effect at High Dilution". Journal of Chemistry 2013 (2013): 1–15. http://dx.doi.org/10.1155/2013/852752.

Texto completo
Resumen
We present a general description of conductivity behavior of highly charged strong polyelectrolytes in dilute aqueous solutions taking into account the translational dielectric friction on the moving polyions modeled as chains of charged spheres successively bounded and surrounded by solvent molecules. A general formal limiting expression of the equivalent conductivity of these polyelectrolytes is presented in order to distinguish between two concentration regimes and to evaluate the relative interdependence between the ionic condensation effect and the dielectric friction effect, in the range of very dilute solutions for which the stretched conformation is favored. This approach is illustrated by the limiting behaviors of three polyelectrolytes (sodium heparinate, sodium chondroitin sulfate, and sodium polystyrene sulphonate) characterized by different chain lengths and by different discontinuous charge distributions.
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Gardiner, Geoffrey W. "Kayexalate (Sodium Polystyrene Sulphonate) in Sorbitol Associated with Intestinal Necrosis in Uremic Patients". Canadian Journal of Gastroenterology 11, n.º 7 (1997): 573–77. http://dx.doi.org/10.1155/1997/370814.

Texto completo
Resumen
BACKGROUND:Kayexalate (sodium polystyrene sulphonate) in sorbitol is commonly used to treat hyperkalemia in patients with renal insufficiency. Isolated case reports and one recent large series have documented intestinal necrosis following administration of kayexalate in sorbitol.METHODS:Two patients with luminal kayexalate crystals associated with intestinal pathology were first identified in the pathology department, and clinicopathological correlation was carried out.RESULTS:Both patients were seriously ill, had prior cardiac surgery and were in renal failure (uremic). Examination of autopsy and colonic resection showed luminal kayexalate crystals associated with underlying mucosal necrosis, submucosal edema and transmural inflammation.CONCLUSION:Although occurring in complex clinical settings, the pathological findings provide additional evidence that kayexalate in sorbitol may be associated with intestinal necrosis and inflammation in uremic patients and that this may be a clinically and pathologically under-recognized iatrogenic bowel injury.
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Bianchi, Stefano y Giuseppe Regolisti. "Pivotal clinical trials, meta-analyses and current guidelines in the treatment of hyperkalemia". Nephrology Dialysis Transplantation 34, Supplement_3 (1 de diciembre de 2019): iii51—iii61. http://dx.doi.org/10.1093/ndt/gfz213.

Texto completo
Resumen
Abstract Hyperkalemia (HK) is the most common electrolyte disturbance observed in patients with advanced stages of chronic kidney disease (CKD), is a potentially life-threatening clinical condition due to an increased risk of fatal arrhythmias, and strongly impacts the quality of life and prognosis of CKD patients. Moreover, while renin–angiotensin–aldosterone system inhibitors (RAASIs) represent the most cardio-nephro-protective drugs used in clinical practice, the treatment with these drugs per se increases serum potassium (sK) values, particularly when heart failure and diabetes mellitus coexist. In fact, the onset or recurrence of HK is frequently associated with not starting, down-titrating or withdrawing RAASIs, and is an indication to begin renal replacement treatment in end-stage renal disease. Current strategies aimed at preventing and treating chronic HK are still unsatisfactory, as evidenced by the relatively high prevalence of HK also in patients under stable nephrology care, and even in the ideal setting of randomized clinical trials. Indeed, dietary potassium restriction, the use of sodium bicarbonate or diuretics, the withdrawal or down-titration of RAASIs, or the administration of old potassium binders, namely sodium polystyrene sulphonate and calcium polystyrene sulphonate, have limited efficacy and are poorly tolerated; therefore, these strategies are not suitable for long-term control of sK. As such, there is an important unmet need for novel therapeutic options for the chronic management of patients at risk for HK. The development of new potassium binders may change the treatment landscape in the near future. This review summarizes the current evidence on the treatment of chronic HK in cardio-renal patients.
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Sportelli, Maria C., Diana Hötger, Rosaria A. Picca, Kyriaki Manoli, Christine Kranz, Boris Mizaikoff, Luisa Torsi y Nicola Cioffi. "Electrosynthesized Polystyrene Sulphonate-Capped Zinc Oxide Nanoparticles as Electrode Modifiers for Sensing Devices". MRS Proceedings 1675 (2014): 15–20. http://dx.doi.org/10.1557/opl.2014.847.

Texto completo
Resumen
ABSTRACTZnO nanoparticles were prepared by a green electrochemical synthesis method applying low current densities followed by a thermal treatment. Sodium polystyrene sulphonate (PSS) was used as stabilizer in the electrolytic aqueous medium due to its biocompatibility and stability. The as-prepared nanocolloids were then annealed to improve their stability, and then converted via hydroxide species into stoichiometric oxide. Different calcination temperatures were studied. ZnO@PSS nanomaterials were deposited onto SiO2/Si substrates, in part in combination with an organic semiconductor layer to evaluate their influence on organic field effect transistors (OFETs). All nanomaterials and composite layers were characterized by morphological and spectroscopic techniques. Promising results regarding the use of ZnO@PSS in OFETs could be demonstrated.
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Filippi, Luca, Alessandra Cecchi, Carlo Dani, Giovanna Bertini, Marco Pezzati y Firmino F. Rubaltelli. "Hypernatraemia induced by sodium polystyrene sulphonate (KayexalateR) in two extremely low birth weight newborns". Pediatric Anesthesia 14, n.º 3 (marzo de 2004): 271–75. http://dx.doi.org/10.1046/j.1460-9592.2003.01210.x.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Avernier, B. H., J. Vliegen, J. Mullens y C. Van Poucke. "Study of the Desorption of Gelatin on Silver Bromide by Means of Sodium Polystyrene Sulphonate". Journal of Photographic Science 34, n.º 4 (julio de 1986): 125–32. http://dx.doi.org/10.1080/00223638.1986.11738411.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Abad, Concepción, Lorenzo Braco, Vicente Soria, Rosa García y Agustín Campos. "Solution properties of polyelectrolytes. I. Exclusion chromatography of sodium polystyrene sulphonate in salt-free water as eluent". British Polymer Journal 19, n.º 6 (noviembre de 1987): 489–500. http://dx.doi.org/10.1002/pi.4980190601.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Laureati, Paola, Yang Xu, Marco Trevisan, Lovisa Schalin, Illaria Mariani, Rino Bellocco, Manish M. Sood et al. "Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study". Nephrology Dialysis Transplantation 35, n.º 9 (4 de agosto de 2019): 1518–26. http://dx.doi.org/10.1093/ndt/gfz150.

Texto completo
Resumen
Abstract Background Despite long-standing clinical use of sodium polystyrene sulphonate (SPS) for hyperkalaemia management in chronic kidney disease (CKD), its safety profile remains poorly investigated. Methods We undertook an observational analysis of nephrology-referred adults with incident CKD Stage 4+ in Sweden during 2006–16 and with no previous SPS use. We studied patterns of use and adverse events associated to SPS initiation during follow-up. Patterns of SPS use were defined by chronicity of treatment and by prescribed dose. We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) associated with SPS initiation (time-varying exposure) for the risk of severe (intestinal ischaemia, thrombosis or ulceration/perforation) and minor (de novo dispensation of laxatives or anti-diarrheal drugs) gastrointestinal (GI) events. Results Of 19 530 SPS-naïve patients with CKD, 3690 initiated SPS during follow-up. A total of 59% took SPS chronically, with an average of three dispensations/year. The majority (85%) were prescribed lower dosages than specified on the product label. During follow-up, 202 severe and 1149 minor GI events were recorded. SPS initiation was associated with a higher incidence of severe adverse events [adjusted HR 1.25 95% CI 1.05–1.49)], particularly in those receiving per label doses [1.54 (1.09–2.17)] and mainly attributed to ulcers and perforations. SPS initiation was also associated with higher incidence of minor GI events [adjusted HR 1.11 (95% CI 1.03–1.19)], regardless of dose, and mainly accounted for by de novo dispensation of laxatives. Conclusions Initiation of SPS in patients with advanced CKD is associated with a higher risk of severe GI complications as well as the initiation of GI-related medications, particularly when prescribed at per label doses.
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Tesis sobre el tema "Sodium polystyrene sulphonate"

1

Obey, T. M. "The configuration of sodium poly(styrene sulphonate) at polystyrene/solution interfaces". Thesis, University of Bristol, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.376486.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

De, Ranjit. "Solution properties of sodium polystyrene sulphonate in 2-ethoxyethanol-water mixed solvent media". Thesis, University of North Bengal, 2011. http://hdl.handle.net/123456789/1435.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Capítulos de libros sobre el tema "Sodium polystyrene sulphonate"

1

"Sodium polystyrene sulphonate." En Drugs Handbook 2012–2013. Bloomsbury Academic, 2011. http://dx.doi.org/10.5040/9781350363595.art-1601.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías ampliadas sobre el tema "Sodium polystyrene sulphonate" para tipos de fuentes particulares:
Artículos de revistas
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía